A monoclonal antibody to endothelial NOS (eNOS) was used to demonstrate the distribution and density of eNOS in the developing porcine lung. Lung tissue from large white pigs aged from less than 5 minutes to 3 months was immunostained and, using light microscopy, distribution of eNOS was assessed by a semiquantitative scoring system. At all ages eNOS was located on the endothelial cells of pulmonary and bronchial arteries and veins. Immunoreactivity for eNOS was greater in the larger, more proximal pulmonary arteries than at the periphery. In the lung of newborn pigs immunoreactivity for eNOS was present in arteries of all sizes but some showed no positive staining. At 2-3 days of age almost all arteries showed positive immunoreactivity. By 3 months of age the amount of eNOS had decreased and was less than that seen in the newborn. The highest level of eNOS was seen immediately after birth when the pulmonary arteries are dilating. eNOS may therefore play an important part in adaptation to extra-uterine life. (Arch Dis Child 1995; 73: F17-F21) 
Persistent pulmonary hypertension of the newborn is associated with the failure of the pulmonary circulation to adapt normally to extra-uterine life. This might be caused by insufficient release of the endothelium derived relaxation factor (EDRF) nitric oxide (NO).1 Some babies have been treated successfully using inhaled NO.2 3 The role of EDRF in the normal process of adaptation is incompletely understood. Acetylcholine stimulation in adult vessels leads, via conversion of L-arginine to L-citrulline by nitric oxide synthase (NOS), to the production of NO and thence to an increase in smooth muscle cell 3'-5'-cyclic guanosine monophosphate (cGMP), causing relaxation.4 The endothelial dependent relaxant response to acetylcholine is absent at birth in porcine intrapulmonary arteries,5 and relatively poor in ovine vessels.6 By 3 days of age, in piglets the response to acetylcholine is present and greater than in the adult.5 Inhaled NO leads to a drop in pulmonary artery pressure in 1 to 2 day old piglets made hypertensive by hypoxia.7 As it is not possible to study human lungs and because previous studies have shown that the structural and functional changes that occur after birth are similar in porcine and human pulmonary arteries,8 the present study in pigs was carried out to determine whether changes in the amount and localisation of endothelial NOS (eNOS) in newborn intrapulmonary arteries would help explain the lack of response to acetylcholine. NOS has several isoforms; the one produced by the endothelial cells is known as type III, and is constitutive, calcium-calmodulin dependent and primarily particulate.9 A recent study on rat lung membranes has demonstrated an increase in NOS III protein and mRNA during late gestation, with a decrease in the immediate postnatal period.'0 We used a monoclonal antibody to constitutive NOS extracted from cultured bovine aortic endothelial cells, known to show immunoreactivity to porcine tissue. 11 Immunocytochemical studies were carried out on fresh lung tissue obtained from normal piglets at intervals from birth (<5 minutes) to 3 months of age.
Methods
Lung tissue was obtained from 29 healthy large white pigs aged <5 minutes (n=5), 2 days (n=4), 3 days (n=5), 5 days (n=3), 10 days (n=7), and 3 months (n=5). For each age group, animals were obtained from different litters. The investigation conforms with the Guide for the care and use of laboratory animals published by the US National Institutes of Health (NIH publication No 85-23; revised 1985) . Within five minutes of death slices of tissue from the mid-lung region were immersed in freshly defrosted 1% paraformaldehyde solution in phosphate buffered saline (PBS: 0-01 M phosphate buffer, pH 7 4, with 0-15 M sodium chloride) for four hours and then washed in PBS containing 10% sucrose for at least 24 hours. After snap freezing, sections 7 ,um thick were cut at 2 1°C in a cryostat. Sections were immersed in 0*03% hydrogen peroxide in methanol for 30 minutes to block endogenous peroxidase, followed by three 10 minute washes in PBS. Non-specific binding was blocked by incubation in 3% normal horse serum for 20 minutes. Sections were then blotted to remove excess serum and incubated overnight with a mouse monoclonal antibody to purified bovine aortic endothelial cell NOS diluted 1 in 10 000 in PBS containing 0*05% bovine serum albumin (BSA) and 0 1% sodium azide. After washing in PBS, sections were successively incubated with biotinylated horse antiserum to mouse IgG (Vector Laboratories, Burlingame, CA, USA) diluted 1 in 100 in PBS with BSA and freshly prepared avidin-biotinylated-peroxidase complex (Vector Laboratories) for 30 and 60 minutes, S,,z' i E F I | I _ |Ni ff~~~~~~~~f *~~~~~M RAE ¢ 11.W Figure 1 Photomicrograph of a small pulmonary artery from a newborn piglet. Positive eNOS reactivity is seen in the endothelial cells. The density ofstaining is particularly strong around the periphery of the cells when they are seen en face at arrows. e=endothelium, m=media.
respectively. Peroxidase activity was demonstrated using the nickel-enhanced diaminobenzidine method. 12 Control sections were treated in the same way except that the primary antiserum was omitted. Adjacent sections were stained with haematoxylin and eosin.
The distribution of eNOS was examined using light microscopy. For the pulmonary arteries a semiquantitative method of assessing the amount of eNOS was used, as the density of colour of the peroxidase stain could not be standardised. Arteries were identified according to their position within the lung. Five types of artery were identified: (1) arteries accompanying bronchioli; (2) arteries accompanying terminal bronchioli; (3) arteries accompanying respiratory bronchioli; (4) arteries accompanying alveolar ducts; and (5) arteries accompanying alveoli. For each artery the amount of NOS was assessed as: (i) none; (ii) up to 50% of the endothelial cells containing eNOS; or (iii) 51-100% of the endothelial cells containing eNOS. For each of the five types of artery, the percentage falling into the three groups was determined. At least 20 arteries of each type were assessed in each animal and in the alveolar duct and alveolar region, at least 50. This assessment was made without the examiner knowing the age of the piglet tissue being examined, and confirmed independently by a co-author. For each age group and each type of artery, the mean value of each of the three percentage groups was determined and the results compared using ANOVA, and, where appropriate, Student's t test with Bonferroni's correction for multiple comparisons. A P value of <0 05 was regarded as having a significant difference.
From these data an average score for the amount of eNOS in the lung tissue was derived in order to help understanding. By multiplying the percentage of vessels with no eNOS by 0, vessels with 1-50% by 0 5, and vessels with 5 1-100% by 1, and adding them together, a score out of 100 was produced for each type of artery. Thus if all arteries studied had 51-100% of their endothelial cells containing NOS the score would be 100. A mean score for each type of artery in each age group was calculated. Because this was a derived figure no statistical methods were used.
Results
NOS was located on the endothelial cells of the pulmonary arteries and veins and the systemic bronchial arteries and veins. The eNOS immunoreactivity was more dense around the edges of the cells particularly when the cells were viewed en face (fig 1) . In the pulmonary arteries the number of cells stained and the density of staining varied with respect to the position of the artery in the branching pathway and with age. By contrast, in pulmonary veins and in the bronchial arteries and veins most endothelial cells contained eNOS at all ages. In the newborn lungs most of the pulmonary arteries accompanying peripheral airways showed some positive immunoreactivity for eNOS, while in the alveolar region only a small number of arteries did so ( fig 2) . The arteries of the 2 and 3 day old animals showed a stronger immunoreactivity in all vessels than was present at birth, including most of the arteries in the alveolar region ( fig 3) . By 5 and 10 days of age the amount of staining was similar to that seen at birth. By 3 months of age, when the pulmonary blood vessels have an adult wall structure,13 there was little staining in the endothelial cells of the arteries in the alveolar region (fig 3) , although the larger arteries and all the veins still showed positive immunoreactivity.
SEMIQUANTITATIVE ASSESSMENT (table)
The amount of eNOS immunoreactivity was greater in larger and more proximal arteries at all ages, with respect to the percentage of arteries which contained eNOS and to the number of endothelial cells in each vessel showing eNOS immunoreactivity. At the level of the bronchioli, at all ages, most arteries had 51-100% of the endothelial cells staining positively for eNOS and only very few showed no eNOS reactivity (0-7% for the six age groups).
At terminal bronchiolar level there were more arteries with no eNOS reactivity and this number was further increased at respiratory bronchiolar level (1-14%, for the age groups).
For arteries at bronchiolar and respiratory bronchiolar level, the percentage of arteries containing 51-100% of cells with eNOS was significantly higher at 2 days of age than at 3 months (p<005).
At alveolar duct level 77% of arteries showed some eNOS reactivity at birth. By 3 days of age all arteries contained eNOS in their endothelium. However, by 3 months of age fewer arteries than at birth had any eNOS present. In the arteries lying within the alveolar walls a third of arteries had no eNOS reactivity at birth. By 3 days only 1-7% had none.
Conversely, arteries with 51-100%/ of their endothelial cells containing NOS increased in number from birth and at 2 and 3 days there were significantly more than at 3 months of age (P<005, 2 and 3 days v 3 months). The derived mean score for the amount of eNOS at each level related to age is shown in fig 4. The score was generally greater in more proximal arteries at all ages. In all types of intrapulmonary artery the score increased between birth and 2 to 3 days of age, and then decreased. The greatest changes were seen in the alveolar wall arteries where the score increased from 56 in the newborn to 98 at 3 days, and then decreased to 29 at 3 months of age.
Thus the overall amount of eNOS in the pulmonary arterial endothelial cells increases between birth and 2 to 3 days, followed by a gradual decrease to the lower level found in the mature lung.
Discussion
Using the monoclonal antibody to type III endothelial NOS, we have demonstrated the presence of eNOS in the porcine intrapulmonary and bronchial arteries and veins, from birth to 3 months of age when the structure of the pulmonary arteries is mature.13 eNOS was located only on the endothelial cells of the vessel wall, as reported in other organs and other species.14 The immunostaining for eNOS was pronounced at cell margins but was present throughout the cytoplasm. A previous electron microscopic study showed that NOS was localised to the plasma membranes of human umbilical vein endothelial cells. 14 The presence of abundant eNOS at birth (greater than in the 3 month old piglet) suggests that porcine pulmonary arteries and veins have the ability to produce NO from the moment of birth. We know that there is a high basal level of cGMP at birth.'5 Perreault and de Marte demonstrated the presence of a basal level of NO in the pulmonary circulation of newborn piglets using Nw-nitro-L-arginine (L.NNA), a competitive inhibitor of NOS.16
The increase in pulmonary vascular resistance seen in response to L.NNA was greater at 1 than at 7 days of age, suggesting that NO may be more important in controlling pulmonary vascular resistance immediately after birth. By contrast, Gordon and Tod, working with isolated sheep lungs, found that in 2 day old animals there were two groups, one in which inhibition of NO production by L.NNA led to an increase in resistance and one where it had no effect.17 This suggests that NO action was still minimal in some lambs at 2 days of age. Cyclic GMP generation in isolated ovine pulmonary arteries increases from late fetal life to 1 week of age and then increases again between 1 and 4 weeks of age.18 This may reflect an increase in the amount of NO production.
Our previous studies on isolated porcine intrapulmonary arteries with endothelium stimulated with acetylcholine showed no relaxation at birth (<5 minutes of age).5 Acetylcholine mediated relaxation was pronounced by 3 days of age and greater than that seen in adult pigs. The initial failure to relax was not due to a lack of eNOS, as demonstrated by the present study, or a lack of cGMP.15 Vasodilatation in response to acetylcholine at 3 to 10 days of age was higher than is seen in adult life5 and occurred at a time when, according to the present study, the pulmonary arteries contain the greatest amount of eNOS. Other endothelial dependent vasorelaxant agonists; bradykinin and A23187, as well as acetylcholine, show an increase in relaxant response after 3 days of age.'9 The failure of acetylcholine to effect relaxation at birth in piglets seems to be due to immaturity of the receptor itself or to a difference in the relaxant signal transduction mechanism in the immature lung, rather than a lack of eNOS or capacity to release NO by the endothelial cells.
The failure to respond to acetylcholine is unlikely to be due to an inability of the smooth muscle cells to relax as the arteries from the newborn pig relax in response to sodium nitroprusside. 5 The present study showed regional as well as age related differences in the amount of eNOS. Such regional differences may have functional implications. Abman6 and Steinhorn20 demonstrated minimal relaxation to acetylcholine in isolated conduit arteries in fetal and newborn sheep, while they have shown a good response in the intact fetus and newborn,21 suggesting greater release of NO from peripheral vessels involved in the whole lung preparation. Similarly, isolated rings of porcine intrapulmonary arteries showed no response at birth to acetylcholine,5 but relaxation was present by 3 days of age,5 19 while whole lung preparations showed greater baseline production of NO at 1 than at 7 days of age. 16 The present study has shown that failure of the large intrapulmonary arteries to dilate is not due to an absence of eNOS. However, the presence of eNOS in the endothelial cells does not mean that it has an active role, and failure of stimulation by receptor mechanisms may prevent the dilatation of these large arteries in vitro. While the amount of eNOS in arteries varied according to the type of intrapulmonary artery and age, in the pulmonary veins the distribution and amount of eNOS immunoreactivity did not change. These morphological Age (days) Figure 4 Mean score for NOS related to age for each arterial level. findings in the pig agree with pharmacological studies on the ovine lung in which a similar high level of basal NO production is seen in veins from 2 day and 1 month old animals,17 suggesting little maturational change. Work on whole lung preparations of lambs has indicated that the contribution of the veins in maintaining a relatively low pulmonary vascular resistance is greater than that of the arteries in the lungs from newborn animals.20
In the porcine lung the overall level of eNOS, as shown by the scoring system, is highest two to three days after birth. The greatest immunoreactivity was found at the time when acetylcholine stimulated relaxation via EDRF is maximal.5 The high level of eNOS may therefore be important in postnatal adaptation. In humans persistent pulmonary hypertension of the newborn is characterised by the persistence of the thick walled pulmonary arterial wall structure of fetal life. The failure to vasodilate may be due to a lack of eNOS at birth, or failure to increase eNOS production for some reason. The effect of hypoxia on the endothelial NOS of the newborn lung is now being investigated.
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